Edward Kim, MD of Levine Cancer Institute discusses the use of immunotherapy combinations for future treatment of patients with lung cancer. This was recorded at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
How will immunotherapy combinations be used in the near term, and what can patients expect from combinations?
By Editor